Literature DB >> 28090172

THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.

B E Engel1, W D Cress1, P G Santiago-Cardona2.   

Abstract

RB1 was the first tumor suppressor gene discovered. Over four decades of work have revealed that the Rb protein (pRb) is a master regulator of biological pathways influencing virtually every aspect of intrinsic cell fate including cell growth, cell-cycle checkpoints, differentiation, senescence, self-renewal, replication, genomic stability and apoptosis. While these many processes may account for a significant portion of RB1's potency as a tumor suppressor, a small, but growing stream of evidence suggests that RB1 also significantly influences how a cell interacts with its environment, including cell-to-cell and cell-to-extracellular matrix interactions. This review will highlight pRb's role in the control of cell adhesion and how alterations in the adhesive properties of tumor cells may drive the deadly process of metastasis.

Entities:  

Keywords:  Adhesion; Cadherin; Cell cycle; Integrin; Retinoblastoma; pRb

Year:  2014        PMID: 28090172      PMCID: PMC5228373          DOI: 10.2147/CHC.S28079

Source DB:  PubMed          Journal:  Cell Health Cytoskelet        ISSN: 1179-1330


  81 in total

Review 1.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.

Authors:  Avery A Sandberg; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2003-08

Review 2.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

3.  Rb regulates fate choice and lineage commitment in vivo.

Authors:  Eliezer Calo; Jose A Quintero-Estades; Paul S Danielian; Simona Nedelcu; Seth D Berman; Jacqueline A Lees
Journal:  Nature       Date:  2010-08-04       Impact factor: 49.962

Review 4.  Molecular mechanisms underlying RB protein function.

Authors:  Frederick A Dick; Seth M Rubin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

Review 5.  Role of the retinoblastoma protein in the pathogenesis of human cancer.

Authors:  W R Sellers; W G Kaelin
Journal:  J Clin Oncol       Date:  1997-11       Impact factor: 44.544

6.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 7.  DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control.

Authors:  N B La Thangue
Journal:  Curr Opin Cell Biol       Date:  1994-06       Impact factor: 8.382

8.  Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.

Authors:  Zhangfeng Zhong; Yuanye Dang; Xia Yuan; Wei Guo; Yingbo Li; Wen Tan; Jingrong Cui; Jinjian Lu; Qingwen Zhang; Xiuping Chen; Yitao Wang
Journal:  Cell Physiol Biochem       Date:  2012-08-02

9.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Authors:  Ellen Heitzer; Martina Auer; Christin Gasch; Martin Pichler; Peter Ulz; Eva Maria Hoffmann; Sigurd Lax; Julie Waldispuehl-Geigl; Oliver Mauermann; Carolin Lackner; Gerald Höfler; Florian Eisner; Heinz Sill; Hellmut Samonigg; Klaus Pantel; Sabine Riethdorf; Thomas Bauernhofer; Jochen B Geigl; Michael R Speicher
Journal:  Cancer Res       Date:  2013-03-07       Impact factor: 12.701

10.  Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors.

Authors:  B E Engel; E Welsh; M F Emmons; P G Santiago-Cardona; W D Cress
Journal:  Cell Death Dis       Date:  2013-11-28       Impact factor: 8.469

View more
  7 in total

Review 1.  The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts.

Authors:  Renier Vélez-Cruz; David G Johnson
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

2.  Rab18 overexpression promotes proliferation and chemoresistance through regulation of mitochondrial function in human gastric cancer.

Authors:  Binge Wu; Rui Qi; Xu Liu; Lehua Qian; Zhongjun Wu
Journal:  Onco Targets Ther       Date:  2018-11-05       Impact factor: 4.147

3.  Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.

Authors:  Fabio Quaglia; Shiv Ram Krishn; Yanqing Wang; David W Goodrich; Peter McCue; Andrew V Kossenkov; Amy C Mandigo; Karen E Knudsen; Paul H Weinreb; Eva Corey; William K Kelly; Lucia R Languino
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

4.  Single-Cell Transcriptomics Reveals the Expression of Aging- and Senescence-Associated Genes in Distinct Cancer Cell Populations.

Authors:  Dominik Saul; Robyn Laura Kosinsky
Journal:  Cells       Date:  2021-11-11       Impact factor: 6.600

5.  Motifs enable communication efficiency and fault-tolerance in transcriptional networks.

Authors:  Satyaki Roy; Preetam Ghosh; Dipak Barua; Sajal K Das
Journal:  Sci Rep       Date:  2020-06-15       Impact factor: 4.379

6.  Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding.

Authors:  Angela Galardi; Marta Colletti; Chiara Lavarello; Virginia Di Paolo; Paolo Mascio; Ida Russo; Raffaele Cozza; Antonino Romanzo; Paola Valente; Rita De Vito; Luisa Pascucci; Hector Peinado; Angel M Carcaboso; Andrea Petretto; Franco Locatelli; Angela Di Giannatale
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

7.  Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.

Authors:  Jaileene Pérez-Morales; Darielys Mejías-Morales; Stephanie Rivera-Rivera; Jonathan González-Flores; Mónica González-Loperena; Fernando Y Cordero-Báez; Wilfredo M Pedreira-García; Camille Chardón-Colón; Jennifer Cabán-Rivera; W Douglas Cress; Edna R Gordian; Teresita Muñoz-Antonia; Mauricio Cabrera-Ríos; Angel Isidro; Domenico Coppola; Marilin Rosa; Theresa A Boyle; Victoria Izumi; John M Koomen; Pedro G Santiago-Cardona
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.